Homologous recombination functions universally in the maintenance of genome stability through the repair of DNA breaks and in ensuring the completion of replication. In some organisms, homologous recombination can perform more specific functions. One example of this is in antigenic variation, a widely conserved mechanism for the evasion of host immunity. Trypanosoma brucei, the causative agent of sleeping sickness in Africa, undergoes antigenic variation by periodic changes in its variant surface glycoprotein (VSG) coat. VSG switches involve the activation of VSG genes, from an enormous silent archive, by recombination into specialized expression sites. These reactions involve homologous recombination, though they are characterized by an unusually high rate of switching and by atypical substrate requirements. Here, we have examined the substrate parameters of T. brucei homologous recombination. We show, first, that the reaction is strictly dependent on substrate length and that it is impeded by base mismatches, features shared by homologous recombination in all organisms characterized. Second, we identify a pathway of homologous recombination that acts preferentially on short substrates and is impeded to a lesser extent by base mismatches and the mismatch repair machinery. Finally, we show that mismatches during T. brucei recombination may be repaired by short-patch mismatch repair.
INTRODUCTION
Homologous recombination is a universal process in living organisms. The central enzyme of this reaction appears to have been conserved in all kingdoms of life (1) and in viruses: RecA in bacteria, Rad51 in eukaryotes, RadA in archaea and UvsX in phageT4 (2) . In each case, the enzyme functions by catalysing the exchange of singlestranded DNA into intact DNA duplex, generating homologous pairing and promoting recombination (3) . Furthermore, each orthologous protein binds singlestranded DNA in the form of a nucleoprotein filament, which has a highly similar structure in Escherichia coli (4), Saccharomyces cerevisiae (5) and Archeoglobus fulgidus (6) . The purpose of homologous recombination is to repair DNA double-strand breaks (3) and to restart stalled or collapsed replication forks (7) . In eukaryotes, it is also used in meiotic recombination (8) and, in some circumstances, telomere maintenance (9) . Beyond these generalized functions, homologous recombination has been coopted into specific functions in a diverse set of organisms. One example is mating type switching in yeast, where homologous recombination is induced by site-directed DNA lesions (10) . In many pathogenic organisms, including bacteria, fungi and protists, homologous recombination can play a similarly specialized role in host immune evasion (11) (12) (13) .
One way pathogens evade immunity is by antigenic variation, the periodic switching of surface antigens. In Trypanosoma brucei, a protistan parasite of mammals in Africa, antigenic variation involves switches in the variant surface glycoprotein (VSG) coat. The success of this strategy relies upon a T. brucei cell expressing a single VSG coat type at any one time, and the ability to switch to an antigenically distinct version, selected from an enormous archive of 41000 silent VSG genes (14) ; for recent reviews see (15) (16) (17) (18) (19) . Singular VSG expression has involved the evolution of telomeric VSG transcription units, termed expression sites (ES), and transcriptional control mechanisms that act upon them. VSG switching is dependent on recombination of the silent VSGs into the ES, and a number of such reactions have been described. The most commonly observed, at least early in T. brucei infections, are gene conversions that generate a copy of a silent VSG and transfer it to the ES. Such gene conversions encompass the VSG ORF and extend to regions of homology upstream and downstream. VSG-associated 70-bp repeats frequently demarcate the upstream conversion boundary (20, 21) , whilst the reaction can extend downstream to short blocks of homology in the VSG 3 0 ends (22) or to the telomeric repeats (23) . Crossover exchanges between chromosome ends, termed reciprocal VSG switches, are also seen (24) . Finally, segmental gene conversions are found where multiple VSG pseudogenes are recombined together to form novel, mosaic VSGs (25, 26) . These have been considered rare events, found late in infections. However, sequencing the T. brucei genome has revealed that VSG pseudogenes represent the substantial majority of the VSG archive (14) , arguing that this is likely to be a significant mechanism of VSG switching (26, 27) .
Growing evidence suggests that VSG switching is closely linked to homologous recombination, since mutations in several key factors of homology-directed strand exchange, including RAD51 (28), a RAD51-related protein called RAD51-3 (29) and BRCA2 (C.Hartley and R.McCulloch, unpublished data), impair the immune evasion process. However, T. brucei VSG switching presents several unusual characteristics. First, the reaction can occur at very high rates (up to 1 Â 10 À2 switches/cell/ generation) (30, 31) , significantly more frequent than the rates of general homologous recombination, which are more typical of random mutation (32) . Second, recombination of VSGs frequently relies on flanking sequences, such as the 70 bp repeats, that are rather short and share limited homology (33, 34) , despite the fact that the T. brucei mismatch repair (MMR) machinery regulates homologous recombination to favour well-matched sequences, and estimates suggest that around 100 bp of homology are needed for efficient RAD51-mediated recombination (35) . Finally, there appears to be a hierarchy in the substrates that are used by general homologous recombination in other organisms: sister chromatids appear to be the favoured substrate in both yeast (36) and mammals (32) , while allelic sequences on chromosome homologues and homologous sequences at ectopic locations are progressively disfavoured (37, 38) . Recombinational activation of allelic VSG sequence on the sister chromatid would not result in a coat switch, compelling the reaction to search for silent VSGs throughout the genome. It has been argued that this is why the VSG archive is predominantly sub-telomeric, as these locations appear to escape such substrate constraints (39) . Beyond that, it is unclear how the other characteristics of VSG switching are accommodated by homologous recombination. One study has suggested that the T. brucei homologous recombination is distinct from that of S. cerevisiae and its relatively close cousin Leishmania, in that the reaction can act on short stretches of homology and may have an elevated rate of strand exchange (40), perhaps indicating modifications of the recombination machinery. Another study has suggested that it may be necessary for T. brucei to suppress MMR to allow homologous recombination to act during VSG switching (33) . Here, we have sought to examine the parameters of homologous recombination in T. brucei in order to address these questions further. To do this we have used a transformation assay that allows us to measure the efficiency of T. brucei recombination, and to assess the pathways that operate.
In previous work, we characterized the T. brucei MMR machinery (41) , which plays a critical role in maintaining genome stability and is conserved throughout evolution. The function of MMR is to recognize and excise base mismatches, which arise through replication errors, by chemical damage or during recombination between incompletely sequence-matched DNA molecules (42, 43) . Eukaryotic MMR is catalysed by homologues of bacterial MutS and MutL proteins, though the machinery has been elaborated, since most eukaryotes encode 3-7 MutSrelated proteins (termed MSH 1-7) and 2-4 MutL-related proteins (MLH1-3 and PMS1-2). Mutation of either MSH2 or MLH1 in T. brucei demonstrates that MMR functions in correcting errors in the nuclear genome (41) . Furthermore, MSH2, and by implication MMR, plays a role in constraining T. brucei homologous recombination to occur between well-matched sequences (35) . A similar anti-recombination role for MMR has long been appreciated in other organisms, where it contributes to the suppression of excessive genome rearrangements and to speciation (44) , though how it occurs remains to be determined fully. In this work, we extend the above analysis to show that T. brucei homologous recombination is strictly dependent on substrate length, in keeping with findings in other organisms. In addition, by comparing the recombination of diverged substrates of different lengths in wild-type cells and in MSH2 mutants, we have identified an MMR-independent homologous recombination pathway and find that a short-patch MMR pathway can correct base mismatches during T. brucei recombination.
MATERIALS AND METHODS

T. brucei strains, growth and transformation
Trypanosoma brucei bloodstream form cells were used and grown at 378C in HMI-9 medium (45). The cells were of strain HTUB (35) , which was derived from the MITat1.2 cell line by insertion of the hygromycin phosphotransferase (HYG) ORF into the tubulin array; MSH2 heterozygous (þ/À) and homozygous (À/À) mutants in this strain have been described before (35) . Transformations to assay recombination efficiency were carried out by electroporation with 3 mg of DNA that had been PCRamplified using Herculase (Stratagene) high-fidelity DNA polymerase (see below). Electroporation conditions were a single pulse at 1.4 kV, 25 mF using a Bio-Rad Gene Pulser II, and at least three transformations were performed for most constructs. For the transformations, T. brucei cells were grown maximally to 3 Â 10 6 cellsÁml À1 , and minimally to 1.5 Â 10 6 cellsÁml À1 , harvested by centrifugation at 600g for 10 min at room temperature, and then re-suspended in Zimmerman post-fusion medium supplemented with 1% D-Glucose (46) to a concentration of 5 Â 10 7 cellsÁml À1 . A total of 2.5 Â 10 7 cells were used per transformation and were allowed to recover following electroporation by growth in 10 ml of non-selective medium for 18 h before antibiotic selection. For this, the cells were harvested as before and then resuspended in HMI-9 containing 2.5 mg.ml À1 phleomycin (Cayla) and spread in 1.0 ml aliquots over a 24-well dish. Between 2 and 10 Â 10 6 cells were plated out in this way, depending on the construct being used (see Supplementary Figure 1) . Transformation rates were measured by the number of wells containing phleomycin-resistant cells after 8-14 days growth. We have assumed that the cell population in each well is clonal, arising from a single transformant, though this underestimates the true number of transformants. However, calculating the likely correct number of transformants in each plate using the number of negative wells, and assuming a Poisson distribution of clones (40), does not alter the nature of the relationship between transformation rate and substrate length or homology (data not shown). In addition, such analysis does not alter significantly the calculated minimum efficient processing segment, which was determined as described by Shen and Huang (1986) .
Generation of HYG targeting constructs
For each transformation construct, 24 PCRs were performed, the products pooled and purified using a Qiagen PCR purification kit according to manufacturer's instructions; 1 QIAquick column was used per six PCRs, and the pooled PCR products resuspended in distilled H 2 O. Each of the different sized PCR products were PCR-amplified either from pHYGwt::BLE, pHYG05::BLE or pHYG11::BLE (35), generating constructs with 0, 5 or 11% base mismatches relative to the HTUB (HYGwt) sequence. The oligonucleotide primers used to generate each construct were size-purified prior to the PCR and are named in Supplementary Figure 1 (sequences can be provided on request); the precise length of each targeting flank in the different PCR products, as well as the number of mismatched bases relative to HYGwt, is also detailed. For reasons that are unclear, a 125 bp construct with 11% sequence divergence could not be PCR-amplified and was omitted from the study. All the purified PCR products were examined by agarose gel electrophoresis to ensure the lack of visible contaminating DNA molecules, and their concentration was determined spectrophotometrically.
Analysis of transformants
The hygromycin sensitivity or resistance of the T. brucei cells was determined by replica passaging 100 ml of the phleomycin-resistant transformants into 1.5 ml of either non-selective HMI-9, or media containing 5 mg.ml À1 hygromycin (Roche). Growth was assessed microscopically 48 h later. For Southern analysis of the transformants, a 15 ml culture was grown to a density of $4 Â 10 6 cellsÁml À1 , harvested by centrifugation as before, resuspended in 500 ml of 1 mM EDTA, 100 mM NaCl, 50 mM Tris-HCl pH 8.0 and lysed overnight at 378C following the addition of SDS to 1% and proteinase K to 100 mg.ml
À1
. DNA was recovered by phenol/chloroform extraction and ethanol precipitation, and then resuspended in distilled H 2 O. The genomic DNA samples were digested by restriction enzymes as described by the manufacturers and separated by electrophoresis, typically at $30 V overnight, on 0.8% agarose gels (Seakem LE agarose, BioWhittaker Molecular Applications) made with 1Â TAE buffer (40 mM Tris, 19 mM acetic acid, 1 mM EDTA) containing 0.2 mg.ml À1 ethidium bromide (Sigma). DNA was blotted by capillary transfer onto hybond-XL membrane (Amersham), probed with a 32 -P labelled DNA generated by random priming and washed to 0.2Â SSC, 0.1% SDS at 658C. Separation of intact T. brucei chromosomes was carried out on a Bio-Rad CHEF-DRIII apparatus. For this, each agarose plug contained $4 Â 10 7 T. brucei cells, which had been grown in HMI-9 to a density of $2 Â 10 6 cellsÁml À1 , centrifuged as before, washed by resuspending the pelleted cells in 10 ml PSG (1 Â PBS, 1% w/v glucose), re-centrifuged and then resuspended in PSG at a concentration of 1.6 Â 10 6 cellsÁml À1 . The cells were then warmed at 378C for 1 min and an equal volume of 1.4% Microsieve low-melt agarose (Flowgen) in H 2 O added and mixed. Disposable plug moulds (BioRad) were filled with $50 ml agarose and placed at 48C for $4 h to set. The agarose plugs were then removed from the moulds, incubated in NDS buffer (0.5 M EDTA, 1 mM Tris base and 34.1 mM lauroyl sarcosine) pH 9.0 containing 1 mg.ml À1 proteinase K at 508C for $24 h, transferred into NDS buffer pH 8.0 containing 1 mg.ml À1 proteinase K at 508C for $24 h, and finally transferred into NDS buffer pH 8.0 for storage at 48C. For electrophoresis, the plugs were washed four times at room temperature in 1 ml of 1Â TB(0.1)E (0.089 M Tris-borate pH 8.0,).2 mM EDTA) for 1 h each, then placed in the wells of a 1.2% agarose (Seakem LE, BioWhittaker Molecular Applications) gel. The gel was electrophoresed at 158C at 2.5 V.cm À1 for 144 h with a 1400-700 s switch time and visualized by staining with 0.5 mg.ml À1 ethidium bromide and UV illumination. Sequences of the integrated DNA constructs were determined by performing PCR amplifications using oligonucleotide primers corresponding to the first and last 20 nt of the HYG ORF and Taq DNA polymerase (ABgene). The resulting PCR products were purified and sequenced using oligonucleotides primers that read upstream and downstream from the bleomycin resistance cassette common to each construct.
RESULTS
Assaying T. brucei homologous recombination by targeted gene replacement Previously, we described an assay to examine homologous recombination efficiency in T. brucei (35) ; this is summarized in Figure 1A . The assay relies upon a hygromycin phosphotransferase ORF (HYG) integrated into the tubulin array (47) on chromosome 1, providing a unique site for recombination. Recombination efficiency is determined by measuring the transformation rate of linear constructs containing a bleomycin resistance cassette (BLE) flanked by sequences derived from HYG. The advantage of this approach is that a single, defined site for recombination is analysed from which a number of parameters can be varied (see below). In addition, using a foreign sequence as a target reduces the potential for recombination into related sequences elsewhere in the genome, an issue that has influenced other studies where endogenous T. brucei sequences are used both as a genomic target and recombination substrate; e.g. (40, 46, 48) . Although transformation of any organism is likely to be affected by a number of factors, including DNA concentration, transformation conditions and growth of the cells, this appears to be a reliable measure of recombination in T. brucei. The same assay has demonstrated the importance of T. brucei MMR in controlling homologous recombination between sequences containing base mismatches (35)(see below). Moreover, related transformation assays have quantified the role in recombination of a number of T. brucei genes, including RAD51 (28,46), MRE11 (48), DMC1 (49) and two RAD51-related genes (RAD51-3 and RAD51-5) (29), and have looked at the importance of target copy number (40) . Most likely, this approach succeeds because virtually all stable transformants in T. brucei integrate linear DNA by homologous recombination, rather than by end-joining processes, and the formation of extra-chromosomal episomes following such transformation has not been described (50) .
Using this assay we have shown previously that T. brucei homologous recombination, acting on substrates with targeting flanks of 450 bp, becomes increasingly less efficient as the level of sequence homology between the flanks and the genomic HYG target decreases (35) . One percent of sequence divergence resulted in a 2.8-fold reduction in transformation efficiency, and 11% divergence caused a near 100-fold reduction. By mutating the T. brucei gene encoding MSH2, we showed that transformation efficiencies of substrates with 2-11% sequence divergence increased by around 9-fold, indicating that MMR is an important regulator of homologous recombination. Nevertheless, it is not the sole factor that determines the success or failure of recombination on such substrates, as the same decline in transformation efficiency with increasing divergence was seen in both MSH2-/-and wild-type cells. In this study, we have examined two further features of T. brucei homologous recombination. First, we tested the relationship between substrate length and recombination efficiency. Second, we asked if MMR has the same influence on homologous recombination between diverged substrates when the length of homology becomes short. To do this, a series of constructs with targeting flanks varying in size from 25 to 200 bp were generated ( Figure 1B ). These were derived by high-fidelity PCR from the previously described constructs with 450 bp flanks (35) that are either perfectly homologous to the genomic HYG sequence (0% sequence divergence), or that contain base mismatches resulting in either 5 or 11% divergence. Linear DNA was prepared by PCR amplification, rather than by restriction digestion, because non-homologous overhangs at the DNA ends, while insignificant for an integration flank of 450 bp, could have larger effects on recombination efficiencies mediated by the shorter substrates. The transformation efficiency of each construct was determined in msh2À/À, MSH2þ/À and wild-type bloodstream stage T. brucei strains (35, 41) . The results of this analysis are graphed in Figures 2 and 3 , and summarized in Tables 1 and 2 .
T. brucei homologous recombination displays a strict dependence on substrate length
Comparing the transformation efficiencies of constructs with 100% sequence identity with the genomic HYG target indicates that T. brucei homologous recombination efficiency is dependent on substrate length. Over the range 200-50 bp, a linear relationship was found between transformation efficiency and substrate length ( Figure 2 ). The average transformation rate for the 50 bp construct in the MMR-proficient cells (MMRþ; either wild type or MSH2 þ/À) was 0.80 AE 0.45 transformants Â 10 À6 cells, corresponding to a near 13-fold reduction in efficiency compared with the 200 bp construct (10.16 AE 0.38 Â 10 À6 ). Beyond this range the linear relationship broke down. It appears that around 50 bp of sequence homology represents a lower threshold for T. brucei recombination, at which point the reaction becomes extremely inefficient: the 25-bp substrate displayed an average transformation rate in MMRþ cells (0.02 AE 0.06 Â 10 À6 ) that was around 500-fold lower than the 200 bp substrate and 40-fold lower than the 50 bp substrate. It is notable, however, that transformants can be generated with 25 bp flanks, and that these can integrate by homologous recombination ( Figure 4 ) (46) . By comparing the transformation rate of the 200 bp construct with the restrictiondigested plasmid containing 450 bp of homologous flank used previously (35) , it appears that the rate of transformation reaches a plateau around 200 bp. This may indicate that T. brucei recombination becomes no more efficient with substrates longer than 200 bp, though it is also possible that this is not a reflection of recombination but represents the maximum transformation efficiency achievable in bloodstream stage cells under these in vitro conditions.
Mutation of MSH2, resulting in T. brucei cells with impaired MMR (MMRÀ), had no discernible effect on recombination for any of 100% homologous constructs in the range 25-200 bp. This contrasts with the 450 bp parental construct, which showed a small (1.6-fold; Figure 3 , Table 1 ) but significant increase in recombination in msh2À/À cells relative to MMRþ cells (35) . Elevation of recombination between similar-sized (350 bp), sequence-matched substrates is seen also in S. cerevisiae MMR mutants (51, 52) . The basis for this is unknown, but its absence on shorter substrates may indicate that MMR acts to suppress recombination on sequence-matched substrates only when they are of a significant length, perhaps because they are more prone to secondary structure during strand exchange.
Recombination of short substrates in T. brucei can occur by an MMR-independent pathway
On 450 bp substrates containing base mismatches relative to the genomic HYG sequence, increasing levels of sequence divergence had an exponentially deleterious effect on T. brucei homologous recombination (35) . Furthermore, mutation of MSH2 resulted in a mean 9-fold elevation in the rate of transformation when sequence divergence was 42% (Figure 3 , Table 1 ). The transformation measurements in this study show that base mismatches and MMR regulation do not have a uniform effect on recombination over the range of substrate length analysed. This can be seen by examining the data in two ways. First, we examined the effect that mutating MSH2 had on recombination of the 5 and 11% diverged substrates (Figures 2 and 3 , Table 1 ). On the 5% diverged substrates, a statistically significant elevation in transformation efficiency in the MMRÀ cells relative to the MMRþ cells was observed only on the 450 and 200 bp substrates. In contrast, though the 5% diverged substrates smaller than 200 bp appeared to show a trend towards a slight increase in transformation in MMRÀ cells, this was not significant.
Comparing the average transformation rates of these constructs confirms this (Table 1) : the 450 and 200 bp substrates displayed 9.3-and 5.3-fold increases, respectively, in transformation rate in the MMRÀ cells relative to MMRþ cells, whereas averaging the data from all substrates below 200 bp revealed a mean 3.4-fold increase (range 1.3-6.7). On the 11% diverged substrates, impairment of MMR caused no significant elevation in transformation efficiency relative to the MMRþ cells on any substrate other than the longest (450 bp).
The second way we examined these data was to compare the transformation rates of the 5 and 11% diverged constructs, in both the MMRþ and MMRÀ cells, relative to the perfectly matched substrates. This is quantified in Table 2 by determining the extent of the reduction in average transformation rate of each 5 or 11% diverged substrate relative to the sequence-matched substrate of cognate length. In both the MMRþ and MMRÀ cells, at virtually all substrate lengths, increasing sequence divergence caused a progressively more severe impairment in transformation rate. However, in MMRþ cells this effect was more pronounced on 450 and 200 bp substrates than on any substrate shorter than 200 bp. The top graph shows transformation rates of constructs with 100% sequence homology (0% sequence divergence) with the genomic HYG target, while the middle graph shows constructs that have 95% homology (5% divergence) and the lower graph shows constructs with 89% homology (11% divergence). Asterisks indicate a statistically significant difference between the transformation rate in the MMRþ and MMRÀ cells (P50.05; two sample t-test). 
Most T. brucei integrative recombination occurs by homologous recombination
An important consideration in the above analysis, and in previous work using the same assay (35) , is whether or not the experimental approach measures T. brucei homologous recombination on all substrates. For instance, it may be that MMR has less influence on recombination of short substrates because primarily non-homologous pathways of recombination act upon such sequences.
Indeed, we have shown that some DNA integration in T. brucei can occur by a pathway mediated by sequence microhomology (46) . Homologous recombination of the constructs into the genomic HYG locus should lead to loss of hygromycin resistance (Hyg S ) due to disruption of the gene by BLE. We therefore tested the antibiotic resistances of a large number of transformants (Figure 4 ), revealing that a significant proportion of transformants in wild type, MSH2þ/À (data not shown) and msh2À/À cells retained hygromycin resistance (Hyg R ). There was, however, no clear relationship between the retention of functional HYG and either substrate size or level of sequence homology. Although the numbers of Hyg R transformants appeared to increase in wild-type cells as substrate length decreased from 200 to 50 bp at 0% divergence, the same trend was not apparent in msh2À/À cells (Figure 4) MMR has an influence on the process that leads to their formation.
To examine the recombination pathway(s) that gives rise to Hyg R transformants, a number of clones were examined by Southern analysis. The large majority of Hyg R transformants had integrated the constructs by homologous recombination. In msh2À/À cells, 20 of the 24 clones examined had maps indicative of HYG disruption by homologous integration of BLE ( Figure 5 ). Reprobing the blot with a portion of the HYG ORF revealed that the antibiotic marker had been duplicated (based on the equivalent signal intensity of the two HYG bands) in these clones, explaining why they retained resistance to hygromycin. The four other Hyg R msh2À/À transformants had not integrated BLE into the tubulin HYG target, but instead into unmapped genomic locations, and the HYG marker was unaltered. A broadly similar pattern of BLE integration was seen for Hyg R transformants in wild-type cells (data not shown). Here, 24 clones were examined, and 23 had disrupted HYG by homologous recombination but retained a functional copy, whilst 1 had integrated BLE into an aberrant genomic location. The greater number of aberrant integrations in the msh2À/À cells may indicate that this minor recombination pathway gains prominence in the absence of MMR. Furthermore, most aberrant integrations were seen using relatively short or diverged substrates: Three of the msh2À/À clones had arisen from 11% diverged substrates of 100 bp ( Figure 5 , lanes 12, 13 and 23) and one had arisen from a 50 bp, 100% homologous substrate ( Figure 5, lane 3) ; the wild type aberrant integrant arose from a 100 bp, 100% homologous substrate.
The above data suggest that two putatively distinct pathways operate in the context of this T. brucei recombination assay to generate hygromycin-resistant transformants. A minor pathway is integration events that do not target the tubulin locus, as directed by the terminal targeting flanks, but into other genomic loci. Although we have not mapped these integrations, the background rate at which they occur is very reminiscent of the microhomology-mediated reactions we have described before (46) . The prevalent pathway, in contrast, is a homologous recombination reaction associated with retention of a functional HYG gene. A number of processes could account for this. First, it is possible that duplication (or amplification) of HYG occurs at a relatively high rate in the growth of these clonal T. brucei lines, perhaps due to recombination within the multigenic tubulin locus. Second, larger scale changes in chromosome copy number (for instance, trisomy arising from replication errors) could be rather common in T. brucei. Finally, it is possible that a form of recombination, termed break-induced replication (53), could be commonly induced by such construct integrations, leading to the duplication of large stretches of chromosome 1, or even the complete chromosome. To examine this, we characterized a selection of Hyg S and Hyg R transformants from wild-type cells by pulsed field gel electrophoresis ( Figure 6 ). One Hyg R transformant (Hyg R 5), which arose as a result of an aberrant integration, contained a novel chromosome, 370 kb in size, that contained BLE and HYG sequence (data not shown). Such alterations in chromosome structure have been seen previously in microhomology-mediated reactions (46) , providing further indirect evidence as to the recombination pathway involved in these integrations. In contrast, no differences in karyotype were seen in the other Hyg R transformants (that had utilized homologous recombination; Hyg R 1-4) when compared with the Hyg S cells or the parental strain, suggesting that large changes in chromosome structure are not associated with these events. Furthermore, probing of a Southern blot of these transformants (Supplementary Figure 3) indicated that there was no difference in the relative amount of chromosomes 1 and 2. Since the tubulin array in which HYG is inserted is located on chromosome 1, this suggests that integration of BLE did not result in the generation of a new copy of the chromosome. Taken together, it seems likely that Hyg R in some transformants is not a consequence of targeted integration by BLE, but results from events that amplify HYG in the tubulin locus and are a constant background process in the HTUB cell lines.
Construct integration occurs by independent invasion of the DNA ends, and mismatches are repaired by short-patch repair
To examine the mechanisms that contribute to the recombination and processing of the constructs during integration, we sequenced the DNA surrounding the homologously integrated BLE marker in a number of transformants clones generated in both wt and msh2À/À cells using constructs with 50, 100, 150 or 200 bp flanks of 5 or 11% sequence divergence. We did not examine any clones that had integrated BLE aberrantly. The results in Figure 7 depict the pattern of residues in the transformant DNA that are mismatched between the constructs and wt HYG target. Most of the transformants had a trans pattern of sequences, in which the majority of mismatched residues corresponded to the sequence of the construct DNA on one side of BLE and the genomic HYG target on the other; no difference in this pattern was observed if the transformants were Hyg R or Hyg S (data not shown). Only clone 9 (from wt cells using a 100 bp, 5% diverged construct) was substantially different, with HYG sequence in both directions. Clone 23 (msh2À/À cells with 200 bp, 5% construct) was somewhat different also, with predominantly HYG-derived residues. Such a trans pattern is consistent with a model for targeted gene replacement in yeast (54) and mammals (55) involving independent strand invasions by both arms of the construct (Figure 9 ). Such a model predicts that heteroduplex DNA can form by strand invasion of each construct end, which can result in 'sectored' or mixed sequence at the mismatched residue positions following replication of the heteroduplex (see Figure 9 ). However, no such mixed sequence was observed in this study: at each position where a base mismatch might from during strand invasion, the sequences were clearly either construct-derived or HYG-derived. This infers either that heteroduplex does not form or that repair of such mismatches is normally rapid and occurs before replication. The distribution of construct and HYG-derived sequences was very similar in the msh2À/À and wt transformants, indicating that if mismatch repair occurs it can proceed independently of MSH2. In each transformant in which construct-derived residues were present in the transformed DNA, this was not continuous along the length of the flank, but was combined with HYG-derived residues. Most likely, HYG-derived residues that are distal to BLE in the flanks of transformants with an otherwise continuous tract of construct-derived sequence (clones 6, 22, 35, 30, 24, 37, 38) result from nucleolytic degradation of the ends of the linear molecules following transformation and before integration. This was most extensive in clone 30 (maximally 76 bp), whereas in a number of other clones mismatched residues close to the ends of the construct molecules had been integrated (e.g. within 15 bp in clones 41 and 15, and 32 bp in clones 37 and 38), arguing that such degradation need not be substantial. In a number of other transformants, the flanks contained a discontinuous pattern of construct and HYG-derived sequence tracts (clones 1, 15, 41, 23) , and some of the residues that were patterned in this way were positioned in close proximity (e.g. separated by only 2 and 8 bpin clones 15 and 23, respectively). This patterning is most simply explained by the formation of heteroduplex DNA during homologous integration and the repair of base mismatches prior to replication by short-patch mismatch repair.
DISCUSSION
The primary conclusion from this work is that T. brucei homologous recombination has substrate characteristics that are typical of those described in other organisms. The significance of this lies in our understanding of the relationship between homologous recombination and the critical immune evasion process of antigenic variation, which involves switches in VSG expression. Genetic evidence points to antigenic variation being closely linked to homologous recombination, despite the fact that VSG gene switching occurs at high rates (30, 31) , often acts upon rather short, diverged sequences (22, 33, 34) and frequently recombines VSGs on different chromosomes to the VSG ES (14, 34) , characteristics that are unusual for stochastic homologous recombination. We have shown previously that the efficiency of T. brucei homologous recombination is dependent on substrate homology, which is at least partially controlled by the T. brucei MMR machinery (35) . We now show here that recombination efficiency is also dependent on substrate length, at least over the range bp. This indicates that specific features of VSG switching have not arisen through modifications of the T. brucei recombination machinery in these two key features. This conclusion is perhaps not surprising, as the primary function of homologous recombination is to repair DNA damage (3) and ensure the completion of replication (7), and therefore fundamental reaction changes could have far-reaching effects on genome integrity. Any specificity of homologous recombination during VSG switching must therefore involve elements or factors that have not yet been uncovered and may be unique to T. brucei. Similar conclusions have been reached regarding antigenic variation in pathogenic Neisseria sp., where convergent evolution has produced a related immune evasion reaction that is also closely linked to homologous recombination (13) .
The relationship we describe in T. brucei between substrate length and recombination rate (measured indirectly as transformation rate) appears to be conserved throughout evolution. In E. coli, three studies have recorded reductions in recombination efficiency over the range 74-20 bp (56), 405-27 bp (57) and 200-25 bp (58). In eukaryotes, S. cerevisiae recombination rate appears to decrease over 960-80 bp (59) or 2 kb-26 bp (60), and in mammalian cells a similar relationship has been recorded between an upper length of around 6.8 (61) to 10 kb (62) and a lower length between $160 (63) and 330 bp (64) . Variations in whether the relationship between recombination rate and substrate length is linear or exponential and in the range of substrate sizes involved, both within and between organisms, presumably reflect differences in the assays used, meaning that it is difficult to compare the absolute sequence requirements of the recombination machineries between each organism. Nevertheless, a sharp drop in recombination efficiency below a lower threshold, referred to as the minimal efficient processing segment (MEPS)(57), has been described in E. coli (57), S. cerevisiae (59) and mammalian cells (63) . We observed the same phenomenon in T. brucei, reinforcing our view that the recombination machinery in the parasite operates in the same manner. Despite this broad evolutionary conservation, previous reports have suggested that T. brucei recombination efficiency is not affected by substrate length over the range 50-400 bp (40, 65) , which is difficult to reconcile with the findings detailed here. One of these reports compared constructs that target distinct genomic locations (40) , and it may be that differences in target accessibility (for instance, through chromatin structure or transcription level) affect recombination efficiency and confounded the analysis. Another explanation may be revealed by linear regression analysis (Figure 8 ), which suggests that the MEPS for T. brucei on sequence-matched substrates is around 31 bp, shorter than the estimates in either S. cerevisiae or mammals ($250 bp) (59), and closer to E. coli (around 25 bp).
Intriguingly, transformation data from Leishmania, a related kinetoplastid parasite, failed to recover any integrants when DNA constructs with less than around 220 bp of targeting flank were used (66) . Though this dichotomy with T. brucei may reflect the limitations of transformation in the two parasites rather than recombination, linear regression analysis of the (albeit limited) data set from Papadopoulou and Dumas (1997) is consistent with a MEPS of 190 bp in Leishmania (Supplementary Figure 2) , closer to the size predicted in the two other eukaryotes. Perhaps, therefore, T. brucei has evolved to allow homologous recombination to operate, with reduced efficiency, on shorter substrates. More analysis will be needed to examine this, but it could be the result of differences in the activity of RAD51, differences in the factors that mediate RAD51 function, or a more active short-sequence recombination pathway.
The second conclusion from this work is that T. brucei contains an MMR-independent, or at least an MSH2-independent, pathway for homologous recombination that has not previously been described. On 5% diverged substrates in the size range 50-175 bp, and on 11% diverged substrates in the range 50-200 bp, this pathway appears to assume considerable significance, but is subordinate to MMR-dependent recombination on longer substrates (450 bp) containing these levels of sequence divergence. This argues that the reaction assumes a greater role during T. brucei homologous recombination as substrate length decreases. Characterization of transformants by antibiotic resistance and Southern analysis suggests that the considerable majority of T. brucei recombination, at all sequence lengths, occurs by homology, suggesting that the MMR-independent reaction is capable of precise integration. We have described a DNA repair process in T. brucei based on the joining of DNA molecules using very short stretches of homology, typically 5-15 bp in length (46) , and similar reactions have been described in other eukaryotes (67, 68) and potentially in bacteria (69-71). Substrate length Figure 8 . Linear regression analysis comparing the relationship between transformation rate and substrate length in T. brucei. Transformation rate was plotted for the combined wild type and MSH2þ/À (MMR proficient; MMRþ) data for the sequence-matched substrates (0% divergence) in Table 1 We suspect that this is not the pathway responsible for most T. brucei MMR-independent recombination, for two reasons. First, examination of the transformation rates of the 5% diverged substrates 175 bp or smaller, and of the 11% diverged substrates 200 bp or smaller, suggests that transformation by the MMR-independent pathway can be as efficient as 1 Â 10 À6 transformants Ácells À1 , since these are conditions in which it is likely that most integrations occur by this route. This is considerably higher than the maximum transformation rate (0.1 x 10 À6 ) described for the microhomology reaction in RAD51 wild-type T. brucei (46) . Second, in most reactions where we have demonstrated that microhomology guides construct integration, this is associated with visible karyotype changes (46) , suggesting that the reaction may be an end-joining process that exploits random DNA breaks, leading to genomic rearrangements. In contrast, such rearrangements are very rare in the extensive numbers of transformation events we have characterized here, including the conditions in which MMR-independent recombination would be expected to be prominent.
The presence of a putative MMR-independent recombination reaction in T. brucei is reminiscent of pathways described in S. cerevisiae, at least superficially. Although Rad51 is a central factor in DNA strand exchange during homologous recombination, some reactions in S. cerevisiae can occur in its absence; reviewed in (72) . Rad52 appears to be essential for nearly all recombination in yeast, suggesting it contributes to both Rad51-dependent and -independent recombination. A relative of Rad52, termed Rad59, was identified in a search for factors required for recombination in S. cerevisiae rad51 mutants (73) , and the suggestion that both proteins contribute to Rad51-independent reactions is supported by findings that each can catalyse strand annealing (74) . Rad59-dependent recombination requires less sequence homology than the Rad51-dependent reaction (53) , and displays a lower degree of regulation by Msh2, and hence MMR, during recombination of diverged DNA sequences (75) . A prediction, therefore, is that that the MMR-independent recombination we see in T. brucei is RAD51-independent. We have not tested this directly, but some data appear consistent with this hypothesis. Linear regression analysis of the data presented here on substrate length and T. brucei transformation rate is best accounted for by two lines of best fit, consistent with two pathways operating (Figure 8 ). Above around $150 bp a pathway predominates that has a MEPS of $100 bp, whereas below $150 bp a distinct pathway with a MEPS of $31 bp. Interestingly, the longer MEPS is consistent with previous estimates of RAD51-dependent T. brucei recombination acting on long (450 bp) substrates (35) . Despite the considerable inefficiency of homologous recombination on substrates shorter than the MEPS, the assay we have used here shows that such recombination can occur, as has been found in yeast (76) , mammalian cells (64) and E. coli (where recombination of 25 bp substrates is predominantly RecA-independent) (58) . Indeed, 80% of the transformants that arose from the constructs with only 25 bp of homology were Hyg S (Figure 3 ), demonstrating that they had integrated by homologous recombination.
In S. cerevisiae, recombination of short substrates around 29-40 bp is not only Rad51-independent, but mutation of Rad51 increases the reaction efficiency (53) . In T. brucei, transformation of constructs with very similar-sized regions of homology (24 bp) occurs at essentially the same frequency in rad51À/À and wild-type cells, suggesting the action of a RAD51-independent pathway (46) . Despite these similarities, it is unclear what factors would catalyse RAD51-independent homologous recombination in T. brucei. Rad52 and Rad59 belong to a superfamily that is not conserved universally (77) , and homologues of both proteins are either absent from the T. brucei genome (78) , or are sufficiently diverged in sequence to have escaped detection. It is therefore possible that T. brucei contains recombination factors, thus far unidentified and distinct from RAD51, that can perform the functions equivalent to the pathway in which Rad59 and Rad52 act in S. cerevisiae.
Identification of an MMR-independent pathway of homologous recombination could be important in understanding antigenic variation and genetic variability in T. brucei. Although antigenic variation is impaired in RAD51 mutants, VSG gene conversion reactions can still be catalysed (28) . It is plausible that the MMRindependent pathway, if it is RAD51-independent, could explain these residual VSG switching events. There is also no evidence that VSG switching is influenced by MMR (35) , which appears to be at odds with the requirement for RAD51, since this pathway should be suppressed by MMR. However, although assays for recombination in yeast rad51 mutants reveal functions for Rad59 in defined recombination pathways, it is very likely that in wild-type cells Rad51, Rad59 and Rad52 actually act together (53, 75) . Trypanosoma brucei VSG switching may therefore occur by a specific recombination pathway that requires RAD51, but is directed towards an MMR-independent route by unidentified factors that act like Rad59. Indeed, this could explain the ability of VSG switching to use rather short and dissimilar DNA sequences as substrates, such as the 70 bp repeats upstream of VSG genes. Furthermore, although nothing is known about the genetic requirements of segmental gene conversion involving the VSG pseudogenes, it is clear that VSG genes share very little primary sequence homology (525% identity between encoded amino acids in 495% of the VSG repertoire; L.Marcello and J.D.Barry, personal communication). It is therefore possible that an MMR-independent reaction, active on short stretches of homology, would be involved. It is important to note that to date we have only assayed T. brucei homologous recombination at one interstitial site. Although some work has suggested that T. brucei recombination occurs at equivalent efficiencies in different genomic locations (40) , it is important to examine this systematically and to assess the pathways used. For instance, it is clear in other organisms that other factors, such as transcription (79) , can influence recombination, and some work has suggested that different pathways of recombination are active in interstitial relative to subtelomeric environments (80) . Moreover, recombination can contribute to the maintenance of telomeres (9) , and the pathway(s) that acts in this regard in T. brucei is unknown (81) .
In any model in which MMR triggers the rejection of recombination between mismatched DNA substrates, heteroduplex DNA must form during the strand exchange step. In MMRþ cells in which recombinants escape rejection, such heteroduplex is likely to be repaired, whereas it should be visible in MMRÀ cells. An MMRindependent pathway may or may not generate heteroduplex, since it could avoid MMR surveillance by using short, perfectly matched sequences or because the strand exchange mechanism between mismatched molecules avoids triggering MMR. We cannot readily distinguish these possibilities through sequencing the integrated DNA in these experiments. In no transformant, even in MMRÀ cells, did we find evidence for the DNA having a mixture of construct and genomic HYG sequence at the mismatched residues, which would arise if heteroduplex formed and was not repaired prior to replication, as illustrated in Figure 9 . Instead, we saw a predominant trans pattern of construct sequence to one side of the integrated marker and HYG sequence on the other. This is most readily explained by independent strand invasion and annealing between a 3 0 single strand on each side of the BLE marker and the genomic HYG target, suggesting that the mechanism of homologous recombination during targeted gene replacement in T. brucei is equivalent to that in yeast and mammals (54, 55) . The one exception we found, where all the sequence is HYG-derived, occurred in wild-type cells (clone 9, Figure 7 ). This could result from MMR of the heteroduplex in favour of the recipient, HYG DNA. Alternatively, it could indicate that construct integration occasionally occurs by annealing of a single strand encompassing both arms of the construct, followed by mismatch repair; such a mechanism has been seen in yeast (82) , though appears to be rare (54) . One distinction between targeted gene replacement in T. brucei and S. cerevisiae is revealed here: mutation of MSH2 in T. brucei either increased the frequency of transformation or had no effect, depending on substrate length, whereas the same mutation in S. cerevisiae results in reduced integration rates (83) . This may indicate that the parasite MSH2 protein does not promote recombination in the ways it has been found to do elsewhere (84) .
The lack of clear evidence for heteroduplex DNA is perplexing. In wild-type cells, the lack of mixed sequence at mismatched residues could be explained by MMR that acts following construct integration and is directed towards one or other DNA strand by, for instance, the direction of replication (Figure 9 ). However, the same pattern was seen in the msh2À/À transformants. In addition, we did not see any striking difference in this pattern as construct length changes, which could arise through a shift in the substrate requirements of the recombination pathways being used. It is conceivable that in all these conditions most strand exchange is limited to perfectly matched sequences between the construct and HYG target, and crossovers then occur on these intermediates to incorporate both strands of the construct DNA. However, a number of findings argue against this. First, we did not observe construct sequence on both sides of BLE, and it is not clear how crossover integration could be directional in this way. Second, it is difficult to explain by this model the rather common appearance of transformants in which tracts of construct sequence were interrupted by patches of HYG sequence in the 'left' arms (clones 1, 15, 41, 23; Figure 7) . Finally, the length of homology that mediates strand pairing would have to have been very short in some cases (e.g. 15 bp in clone 41, and 12 bp in clones 6, 35 and 30; Figure 7 ). For these reasons, we suggest that heteroduplex does form during homologous integration and that it is repaired by shortpatch MMR. This would explain the predominant pattern of sequence we see in the integrated DNA (Figure 9 ). Furthermore, it most readily explains transformants in which construct-derived and HYG-derived residues were found in close proximity. Such a situation is consistent with repair of two putative mismatches in different directions (in favour of the invading and recipient strands), which is distinct from long-patch MMR, where a mismatch triggers excision of extensive regions of DNA to allow repair (43) . However, given that the trans pattern of sequence in the transformants was predominantly with construct sequence to the 'left' of BLE and HYG sequence to the 'right', and that many tracts were continuous stretches of either construct or HYG residues, it seems likely that some feature(s) biases the direction of shortpatch repair. The nicks that are present during strand invasion cannot explain this, as repair would then be in the same direction for each end of the construct. Replication or transcription seems like a reasonable alternative, though this cannot be absolute, since we see discontinuous tracts in a number of transformants, and one clone has reversed the predominant pattern (clone 23; Figure 7 ). Short-patch MMR has not been described in T. brucei, but has been found in other organisms (including during recombination), though the molecular machinery is still being described (85, 86) . A consequence of the lack of identifiable heteroduplex DNA in this study is that we cannot determine how extensive the lengths of strand exchange intermediates are in these experiments, nor whether this differs in wild-type and msh2À/À cells, as has been reported in yeast (87, 88) . In addition, this approach does not allow us to test our hypothesis that the putative MMR-independent pathway we propose utilizes shorter substrates. However, given the existence of mixed tracts of construct and HYG sequence at all substrate lengths, it is likely that heteroduplex is formed in all conditions.
A footnote in this study, which was not appreciated in our previous analyses (35) , is that we find significant levels of duplication of the HYG locus in this assay. The available evidence suggests that this is due to the generation of additional copies of HYG in the tubulin array during growth of the clonal HTUB T. brucei cell lines, rather than being a consequence of the targeted gene replacement. This 'spread' of a resistance marker in tubulin has been described previously (89) , and shown to be due to unequal sister chromatid exchange. At least in our experiments this appears to be rather frequent. Though this may be a result of the antibiotic exerting a selective pressure for increased gene product, it is notable that high frequencies of allelic gene conversion have been described in T. brucei (90) and that considerable variation in repetitive sequences has been described between T. brucei strains (91) . Our data also hint that impairment in MMR may enhance HYG amplification, perhaps because MMR-mediated suppression of recombination between divergent sequences is alleviated, leading to greater rearrangements in the T. brucei genome.
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